New Immunotherapy Treatment Darzalex For Multiple Myeloma Cancer1

Darzalex (daratumumab) is a recent FDA approved immunotherapy for the treatment of multiple myeloma cancer. In this video, Dr. Stephen Lemon, a medical oncologist, talks about how this immunotherapy treatment works, including what types of side effects it may cause.

Darzalex is developed by Janssen Biotech. Stephen Lemon MD is a medical oncologist who is not affiliated with Janssen Biotech.

Click on the buttons below to view more videos that we have produced

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email